Wednesday, December 7

Tag: advice

Exclusively Female Chess Tournaments: Why?
Entertainment

Exclusively Female Chess Tournaments: Why?

In some competitions, a man’s greater physical strength is irrelevant, such as chess or billiards. Yet tournaments are hosted for women only. How is this justified? Or is it that the women can’t beat the men? —Randal P., St. Louis, Missouri(scroll to keep reading)Both these pursuits were invented by men and have a long history of male interest and involvement. Women have only recently begun to even consider participation, and they may never find them compelling enough to join in large numbers. Note that 85 percent of the members of the U.S. Chess Federation are male. Hosting events for women may be a well-intentioned effort to encourage more female activity, but they imply inferiority, which is inherently damaging.Related: What Are Marilyn's Chess Tips?!function(f,b,e,v,n,t,s){if(f.fbq)re...
Business

Thermo Fisher Scientific’s Clinical Research Business Named a Leader in Decentralized Clinical Trial Solutions by ISG

WILMINGTON, N.C.--(BUSINESS WIRE)-- The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been distinguished for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm. The business was recognized as an ISG Provider Lens Leader for its digital transformation services, including customer solutions for clinical development and patient engagement. This marks the second consecutive year the business has been acknowledged by ISG. In its 2021 ISG Provider Lens™ Life Sciences Digital Services Global Report, ISG recognized Thermo Fisher’s clinical research business with a clinical development leader designation for its skill and dexteri...
Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper
Science

Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper

CAMBRIDGE, MA / ACCESSWIRE / May 10, 2022 / Biobohemia's scientists share in a released paper ("Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions") the experience gained over the past year in advancing antigen essence technology, including that related to relationships with contract manufacturing organizations, the upgrading of existing experimental cancer vaccines, and the legal and ethical aspects of the technology.Biobohemia is a pioneer in work on antigenic essence, a new technology for the creation of cancer vaccines. Although this technology has been recognized as a promising platform for this purpose ("Cancer Vaccine Platforms", Report 2022), its novelty poses unique challenges. The released paper describes the experience gained by the...